- Home
- VSCO vs ARWR Comparison
VSCO vs ARWR Comparison
Compare VSCO & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- ARWR
- Stock Information
- Founded
- VSCO 1977
- ARWR 2003
- Country
- VSCO United States
- ARWR United States
- Employees
- VSCO N/A
- ARWR N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- VSCO Consumer Discretionary
- ARWR Health Care
- Exchange
- VSCO Nasdaq
- ARWR Nasdaq
- Market Cap
- VSCO 2.1B
- ARWR 2.5B
- IPO Year
- VSCO N/A
- ARWR 1993
- Fundamental
- Price
- VSCO $26.28
- ARWR $29.42
- Analyst Decision
- VSCO Hold
- ARWR Strong Buy
- Analyst Count
- VSCO 12
- ARWR 8
- Target Price
- VSCO $26.08
- ARWR $47.75
- AVG Volume (30 Days)
- VSCO 3.4M
- ARWR 2.8M
- Earning Date
- VSCO 08-28-2025
- ARWR 08-07-2025
- Dividend Yield
- VSCO N/A
- ARWR N/A
- EPS Growth
- VSCO 6.76
- ARWR N/A
- EPS
- VSCO 1.86
- ARWR N/A
- Revenue
- VSCO $6,265,000,000.00
- ARWR $572,976,000.00
- Revenue This Year
- VSCO $3.84
- ARWR $22,306.37
- Revenue Next Year
- VSCO $2.44
- ARWR N/A
- P/E Ratio
- VSCO $14.24
- ARWR N/A
- Revenue Growth
- VSCO 2.29
- ARWR 2816.20
- 52 Week Low
- VSCO $13.76
- ARWR $9.57
- 52 Week High
- VSCO $48.73
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- VSCO 62.02
- ARWR 72.20
- Support Level
- VSCO $25.84
- ARWR $28.12
- Resistance Level
- VSCO $28.06
- ARWR $31.13
- Average True Range (ATR)
- VSCO 1.32
- ARWR 1.54
- MACD
- VSCO 0.23
- ARWR 0.23
- Stochastic Oscillator
- VSCO 71.05
- ARWR 83.02
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.